Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,068 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. Mocroft A, et al. Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17. Lancet HIV. 2016. PMID: 26762990 Clinical Trial.
Experimental bilayer zirconia systems after aging: Mechanical, optical, and microstructural characterization.
Sousa EO, Alves LMM, Campos TMB, Bergamo ETP, Benalcazar-Jalkh EB, Marun MM, Galli MZ, Carvalho LF, Dos Santos C, Tebcherani SM, Thim GP, Zhang Y, Yamaguchi S, Witek L, Coelho PG, Bonfante EA. Sousa EO, et al. Among authors: galli mz. Dent Mater. 2025 Jan 13:S0109-5641(24)00362-2. doi: 10.1016/j.dental.2024.12.012. Online ahead of print. Dent Mater. 2025. PMID: 39809617
Shaping the Emission Directivity of Single Quantum Dots in Dielectric Nanodisks Exploiting Mie Resonances.
Cruciano C, Rocco D, Genco A, Tognazzi A, Locatelli A, Carletti L, Fedorov A, Trovatello C, Di Blasio G, Bargigia I, Louca C, Gubian P, Tavani G, Lovisolo L, Tuktamyshev A, Andreani LC, Galli M, Cerullo G, Leo G, Sanguinetti S, De Angelis C, Bollani M. Cruciano C, et al. Among authors: galli m. ACS Nano. 2025 Jan 11. doi: 10.1021/acsnano.4c13327. Online ahead of print. ACS Nano. 2025. PMID: 39797816
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.
Martino EA, Palmieri S, Galli M, Derudas D, Mina R, Della Pepa R, Zambello R, Vigna E, Bruzzese A, Mangiacavalli S, Zamagni E, Califano C, Musso M, Conticello C, Cerchione C, Mele G, Di Renzo N, Offidani M, Tarantini G, Casaluci GM, Rago A, Ria R, Uccello G, Barilà G, Palumbo G, Pettine L, De Magistris C, Vincelli ID, Brunori M, Accardi F, Amico V, Amendola A, Fontana R, Bongarzoni V, Rossini B, Cotzia E, Gozzetti A, Rizzi R, Sgherza N, Curci P, Mancuso K, Reddiconto G, Maroccia A, Franceschini L, Bertuglia G, Nappi D, Barbieri E, Quaresima M, Petrucci MT, Di Raimondo F, Neri A, Tripepi G, Musto P, Morabito F, Gentile M. Martino EA, et al. Among authors: galli m. ESMO Open. 2025 Jan 7;10(2):104084. doi: 10.1016/j.esmoop.2024.104084. Online ahead of print. ESMO Open. 2025. PMID: 39778329 Free article.
Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial.
Richardson P, Beksaç M, Oriol A, Lindsay J, Schjesvold F, Galli M, Yağcı M, Larocca A, Weisel K, Yu X, Donahue C, Acosta J, Peluso T, Dimopoulos M. Richardson P, et al. Among authors: galli m. Eur J Haematol. 2025 Jan 8. doi: 10.1111/ejh.14365. Online ahead of print. Eur J Haematol. 2025. PMID: 39777934
2,068 results